Back to doctors
Univ.-Prof. Dr. Shahrokh F.  Shariat

Univ.-Prof. Dr. Shahrokh F. Shariat

Urology
Urological oncology
Urological surgery
Vienna, Austria |
German
English
Univ. Prof. Dr. Shahrokh Shariat is a head of the University Department of Urology at Vienna General Hospital. Here he has been treating and operating on patients with special issues and also severe, complex diseases since 2013. At the Clinic for Urology, people with prostate cancer, bladder cancer, kidney cancer,...more
Initial consultation
Video call | 0.5h
Duration: up to 30 minutes
470 €

Experience

  • Adjunct Professor of Urology University of Texas Southwestern Medical Center, Dallas, TX, USA

  • Adjunct Professor of Urology and Medical Oncology Weill Cornell Medical Center, New York, NY, USA

Certificates

  • He is the recipient of more than 80 national and international scientific awards, including the highest awards of the European (EAU, Matula Award 2014) and American (AUA, Gold Cystoscope 2017) Urological Associations

  • Matula Award of the European Urological Association

  • Gold Cystoscope 2017 of the American Urological Association

Memberships

  • The medical advisory board of two charities, director

  • Medical charity for refugees, director

  • Editorial board of various journals such as European Urology, BJU International, World Journal of Urology, Current Opinion in Urology (editor-in-chief) and Immunotherapy

  • Journals, conference proceedings and grants for numerous national and international organizations

  • The upper tract urothelial carcinoma collaboration, head

  • Bladder cancer detection group, head

  • 25 academic societies and on the editorial boards of 26 scientific journals. Bladder Cancer Research Consortium, head

Publications

  • pdf In 2016, he broke the Google h-index of 100 and published more than 900 peer-reviewed original articles and has authored 14 book chapters, and is consulted as an expert by 25 scientific societies

His research interests include urologic oncology - molecular mechanisms, markers, early detection, natural history, treatment, translational research and outcomes. Specifically, Dr. Shariat works on the discovery, testing, and validation of molecular markers associated with the biological and clinical behavior of prostate and urothelial cancers. His laboratory research focuses on integrative genomics and epigenomics of urothelial carcinomas with the goal of developing personalized therapeutic strategies.

Specially, Dr. Shariat has been working on the discovery, testing, and validation of molecular markers associated with the biological and clinical behavior of prostate and urothelial cancers. His laboratory research focuses on integrative genomics and epigenomics of urothelial carcinoma with the goal of designing personalized therapeutic strategies.


Initial consultation
Video call | 0.5h
Duration: up to 30 minutes
470 €